Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Calabresi

Showing results (31-40 of 169) with videos related to

Pageof 17
Sort By:
Atherosclerosis|November 18, 2006
Effects of fenofibrate and simvastatin on HDL-related biomarkers in low-HDL patientsGuido Franceschini, Laura Calabresi, Cinzia Colombo, et al.
Journal of Lipid Research|February 4, 2003
Apolipoprotein composition and particle size affect HDL degradation by chymase: effect on cellular cholesterol effluxMiriam Lee, Petri T Kovanen, Gabriella Tedeschi, et al.
International Journal of Molecular Sciences|July 29, 2025
CD20+ T Cells in Multiple Sclerosis: From Pathogenesis to Treatment-Induced DepletionAnna Chiara Mazzeo, Laura Calabresi, Valentina Damato, et al.
Pharmacological Research|February 10, 2007
Tolerability of statins is not linked to CYP450 polymorphisms, but reduced CYP2D6 metabolism improves cholesteraemic response to simvastatin and fluvastatinPiergiorgio Zuccaro, Giuliana Mombelli, Laura Calabresi, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 21, 2003
Synthetic high-density lipoproteins exert cardioprotective effects in myocardial ischemia/reperfusion injuryGiuseppe Rossoni, Monica Gomaraschi, Ferruccio Berti, et al.
Pharmacological Research|August 7, 2002
Omega-3 fatty acid ethyl esters increase heart rate variability in patients with coronary diseaseBarbara Villa, Laura Calabresi, Giulia Chiesa, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 23, 2010
Macrophage, but not systemic, apolipoprotein E is necessary for macrophage reverse cholesterol transport in vivoIlaria Zanotti, Matteo Pedrelli, Francesco Potì, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|November 17, 2006
Structure, function and amyloidogenic propensity of apolipoprotein A-ILaura Obici, Guido Franceschini, Laura Calabresi, et al.
Biochemistry|June 8, 2010
Conformation of dimeric apolipoprotein A-I milano on recombinant lipoprotein particlesShaila Bhat, Mary G Sorci-Thomas, Laura Calabresi, et al.
FEBS Letters|October 21, 2006
Inhibition of MMP-2 activation and release as a novel mechanism for HDL-induced cardioprotectionStefano Bellosta, Monica Gomaraschi, Monica Canavesi, et al.
Pageof 17

Showing results (31-40 of 169) with videos related to

Sort By:
Pageof 17
Atherosclerosis|November 18, 2006
Effects of fenofibrate and simvastatin on HDL-related biomarkers in low-HDL patientsGuido Franceschini, Laura Calabresi, Cinzia Colombo, et al.
Journal of Lipid Research|February 4, 2003
Apolipoprotein composition and particle size affect HDL degradation by chymase: effect on cellular cholesterol effluxMiriam Lee, Petri T Kovanen, Gabriella Tedeschi, et al.
International Journal of Molecular Sciences|July 29, 2025
CD20+ T Cells in Multiple Sclerosis: From Pathogenesis to Treatment-Induced DepletionAnna Chiara Mazzeo, Laura Calabresi, Valentina Damato, et al.
Pharmacological Research|February 10, 2007
Tolerability of statins is not linked to CYP450 polymorphisms, but reduced CYP2D6 metabolism improves cholesteraemic response to simvastatin and fluvastatinPiergiorgio Zuccaro, Giuliana Mombelli, Laura Calabresi, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 21, 2003
Synthetic high-density lipoproteins exert cardioprotective effects in myocardial ischemia/reperfusion injuryGiuseppe Rossoni, Monica Gomaraschi, Ferruccio Berti, et al.
Pharmacological Research|August 7, 2002
Omega-3 fatty acid ethyl esters increase heart rate variability in patients with coronary diseaseBarbara Villa, Laura Calabresi, Giulia Chiesa, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 23, 2010
Macrophage, but not systemic, apolipoprotein E is necessary for macrophage reverse cholesterol transport in vivoIlaria Zanotti, Matteo Pedrelli, Francesco Potì, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|November 17, 2006
Structure, function and amyloidogenic propensity of apolipoprotein A-ILaura Obici, Guido Franceschini, Laura Calabresi, et al.
Biochemistry|June 8, 2010
Conformation of dimeric apolipoprotein A-I milano on recombinant lipoprotein particlesShaila Bhat, Mary G Sorci-Thomas, Laura Calabresi, et al.
FEBS Letters|October 21, 2006
Inhibition of MMP-2 activation and release as a novel mechanism for HDL-induced cardioprotectionStefano Bellosta, Monica Gomaraschi, Monica Canavesi, et al.
Pageof 17